Photobiomodulation in the treatment of xerostomia associated with hyposalivation in a pediatric patient with systemic scleroderma

Oliveira, Analú Barros de; Ferrisse, Túlio Morandin; Salomão, Karina Borges; Miranda, Marina Lins; Bufalino, Andréia; Brighenti, Fernanda Lourenção

doi:10.4322/acr.2020.220

Cited by 6 publications

(1 citation statement)

References 16 publications

(18 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this specific case, the irradiated spots were the sublingual, parotid glands, and submandibular glands. It was possible to verify salivary increase and total remission of xerostomia, in addition to the improvement in chewing and swallowing (Oliveira et al, 2020). Lončar B. et.…”

Section: Glands Diseasesmentioning

confidence: 99%

Photobiomodulation in the treatment of oral diseases

Luna

Guimarães²,

Silva³

et al. 2023

RSD

View full text Add to dashboard Cite

The modern conception of dentistry is based on the search for noninvasive clinical applicability methods that improve the prognoses of dental pathologies and, therefore, the interest in light-tissue interaction technology has increased in the last decade. The present study aims to explore the applicability of photobiomodulation (PBM) in dentistry with emphasis on wavelengths provided to target tissues and the underlying mechanisms of action of lasers observed in the treatment of various oral diseases, as well as the affected processes that include, but are not limited to wound healing, tissue biostimulation, tissue and nerve regeneration, inhibition of pain and inflammatory processes. The effects obtained through photobiomodulation are correlated with the parameters involved, such as the equipment used, wavelength, power dosages, irradiation duration, energy density, general patient conditions, target tissue, pathology and etiologies considered. Depending on the conditions reported, the photobiomodulator effect or also known as low intensity laser therapy (LLLT) influences the increase of cellular metabolism through the application of photonic energy that presents monochromaticity and propagates consistently in time and space. Thus, the protocols for the application of the photonic properties of this therapeutic modality should be analyzed in the treatment of oral conditions and pathologies associated with glandular, neural, autoimmune, traumatic, and idiopathic diseases.

show abstract

Section: Glands Diseasesmentioning

confidence: 99%

Photobiomodulation in the treatment of oral diseases

Luna

Guimarães²,

Silva³

et al. 2023

RSD

View full text Add to dashboard Cite

show abstract

Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers

et al. 2022

View full text Add to dashboard Cite

Introduction Skin ulcers (SU) represent one of the most frequent manifestations of systemic sclerosis (SSc), occurring in almost 50% of scleroderma patients. SSc-SU are often particularly difficult to treat with conventional systemic and local therapies. In this study, a preliminary evaluation of the role and effectiveness of blue light photobiomodulation (PBM) therapy with EmoLED ® in the treatment of scleroderma skin ulcers (SSc-SU) was performed. Methods We retrospectively analyzed 12 consecutive SSc patients with a total of 15 SU on finger hands. All patients were treated with adequate systemic therapy and local treatment for SU; after a standard skin ulcer bed preparation with debridement of all lesions, EmoLED ® was performed. All patients were locally treated every week during 2 months of follow-up; SU data were collected after 4 weeks (T4) and 8 weeks (T8). Eight SSc patients with comparable SU were also evaluated as controls. Results The application of EmoLED ® in addition to debridement apparently produced faster healing of SU. Complete healing of SU was recorded in 41.6% cases during EmoLED ® treatment. Significant improvements in SU area, length, and width, wound bed, and related pain were observed in EmoLED ® patients from T0 to T8. Control subjects treated with standard systemic/local therapies merely showed an amelioration of SU area and width at the end of the follow-up. No procedural or post-procedural adverse events were reported. Conclusions The positive clinical results and the absence of side effects suggest that EmoLED ® could be a promising tool in the management of SSc-SU, with an interesting role to play in the healing process in addition to conventional systemic and local treatments.

show abstract

Photobiomodulation Literature Watch November 2021

Carroll¹

2022

Photobiomodulation, Photomedicine, and Laser Surgery

View full text Add to dashboard Cite

Photobiomodulation in the treatment of xerostomia associated with hyposalivation in a pediatric patient with systemic scleroderma

Cited by 6 publications

References 16 publications

Photobiomodulation in the treatment of oral diseases

Photobiomodulation in the treatment of oral diseases

Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers

Photobiomodulation Literature Watch November 2021

Contact Info

Product

Resources

About